(Q45305395)

11 December 2017

title

TRACK-HD: both promise and disappointment (English)

1 reference

11 December 2017

1

Karl Kieburtz

1 reference

11 December 2017

Charles Venuto

2

1 reference

11 December 2017

publication date

2 December 2011

1 reference

11 December 2017

1 reference

11 December 2017

volume

11

1 reference

11 December 2017

issue

1

1 reference

11 December 2017

page(s)

24-25

1 reference

Biomarkers and surrogate endpoints: preferred definitions and conceptual framework

11 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970285-X

7 January 2021

Tetrabenazine as antichorea therapy in Huntington disease: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970285-X

7 January 2021

Pridopidine for the treatment of motor function in patients with Huntington's disease (MermaiHD): a phase 3, randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970285-X

7 January 2021

Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970285-X

7 January 2021

Detection of Huntington's disease decades before diagnosis: the Predict-HD study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970285-X

7 January 2021

At risk for Huntington disease: The PHAROS (Prospective Huntington At Risk Observational Study) cohort enrolled

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970285-X

7 January 2021

Optimizing the ongoing search for new treatments for Parkinson disease: using futility designs

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970285-X

7 January 2021

10.1016/S1474-4422(11)70285-X

Identifiers

DOI

1 reference

11 December 2017

1 reference